MedPath
HSA Approval

STANDACILLIN FOR INJECTION 0.5 g/vial

SIN00680P

STANDACILLIN FOR INJECTION 0.5 g/vial

STANDACILLIN FOR INJECTION 0.5 g/vial

May 3, 1988

NOVARTIS (SINGAPORE) PTE LTD

NOVARTIS (SINGAPORE) PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderNOVARTIS (SINGAPORE) PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, POWDER, FOR SOLUTION

INTRAVENOUS, INTRAMUSCULAR

Medical Information

J01CA01

ampicillin

Manufacturer Information

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ GMBH

Active Ingredients

AMPICILLIN SODIUM EQV AMPICILLIN

500 mg/vial

Ampicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

STANDACILLIN FOR INJECTION 0.5 g/vial - HSA Approval | MedPath